Director/PDMR Shareholding

GlaxoSmithKline PLC
30 November 2005




   Notification of Transactions of Directors, Persons Discharging Managerial
                      Responsibility or Connected Persons


I give below details of changes in the interests of Directors, Persons
Discharging Managerial Responsibility or Connected Persons in the Ordinary
Shares of GlaxoSmithKline plc.



   GlaxoSmithKline plc received notification from the Administrators of the
   GlaxoSmithKline US Retirement Savings Plan ("the Plan") on 29 November 2005,
   that as a result of a movement in the fund on 23 November 2005, the number of
   Ordinary Share ADRs held by the fund had changed from 18,460,229 to 
   18,440,842 at an average price of $49.92.




The Plan is a discretionary fund of which all employees or former employees of
GlaxoSmithKline plc and its subsidiaries are potential beneficiaries. Two of the
Company's directors, Dr J P Garnier and Dr T Yamada are therefore potentially
interested in the shares held in the fund from time to time in the same way as
other employees or former employees of GlaxoSmithKline plc and its subsidiaries.


This notification relates to a transaction notified in accordance with
Disclosure Rule 3.1.4R(1)(b).





S M Bicknell
Company Secretary



30 November 2005


                      This information is provided by RNS
            The company news service from the London Stock Exchange